{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T03:14:59Z","timestamp":1788232499398,"version":"build-2803163510"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"DOI":"10.1007\/s00592-026-02792-4","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T03:02:43Z","timestamp":1788231763000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of dapagliflozin on proteinuria, glycemic control, and treatment burden in diabetic kidney transplant recipients: a matched cohort study"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3162-8760","authenticated-orcid":false,"given":"Zeynep","family":"Ural","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulver","family":"Derici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"issue":"2","key":"2792_CR1","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jcjd.2021.06.003","volume":"46","author":"S Shuster","year":"2022","unstructured":"Shuster S, Al-Hadhrami Z, Moore S, Awad S, Shamseddin MK (2022) Use of sodium-glucose cotransporter-2 inhibitors in renal transplant patients with diabetes: a brief review of the current literature. Can J Diabetes 46(2):207\u2013212 (Epub 2021 Jun 19)","journal-title":"Can J Diabetes"},{"issue":"11","key":"2792_CR2","doi-asserted-by":"publisher","first-page":"e772","DOI":"10.1097\/TXD.0000000000001228","volume":"7","author":"Y Hisadome","year":"2021","unstructured":"Hisadome Y, Mei T, Noguchi H, Ohkuma T, Sato Y, Kaku K, Okabe Y, Nakamura M (2021) Safety and efficacy of sodium-glucose cotransporter 2 inhibitors in kidney transplant recipients with pretransplant type 2 diabetes mellitus: a retrospective, single-center, inverse probability of treatment weighting analysis of 85 transplant patients. Transpl Direct 7(11):e772. https:\/\/doi.org\/10.1097\/TXD.0000000000001228","journal-title":"Transpl Direct"},{"key":"2792_CR3","doi-asserted-by":"publisher","unstructured":"Patel N, Hindi J, Farouk SS (2021) Sodium-glucose cotransporter 2 inhibitors and kidney transplantation: what are we waiting for? Kidney 2(7):1174\u20131178. https:\/\/doi.org\/10.34067\/KID.0000732021","DOI":"10.34067\/KID.0000732021"},{"issue":"5","key":"2792_CR4","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1159\/000501854","volume":"44","author":"M Mahling","year":"2019","unstructured":"Mahling M, Schork A, Nadalin S, Fritsche A, Heyne N, Guthoff M (2019) Sodium-glucose cotransporter 2 (SGLT2) inhibition in kidney transplant recipients with diabetes mellitus. Kidney Blood Press Res 44(5):984\u2013992. https:\/\/doi.org\/10.1159\/000501854 (Epub 2019 Aug 22)","journal-title":"Kidney Blood Press Res"},{"issue":"1","key":"2792_CR5","doi-asserted-by":"publisher","first-page":"10043","DOI":"10.1038\/s41467-024-54171-8","volume":"15","author":"JY Sheu","year":"2024","unstructured":"Sheu JY, Chang LY, Chen JY, Pan HC, Tseng CS, Chueh JS, Wu VC (2024) The outcomes of SGLT-2 inhibitor utilization in diabetic kidney transplant recipients. Nat Commun 15(1):10043. https:\/\/doi.org\/10.1038\/s41467-024-54171-8","journal-title":"Nat Commun"},{"issue":"3","key":"2792_CR6","doi-asserted-by":"publisher","first-page":"101627","DOI":"10.1016\/j.diabet.2025.101627","volume":"51","author":"T Diker Cohen","year":"2025","unstructured":"Diker Cohen T, Polansky A, Bergman I, Ayada G, Babich T, Akirov A, Steinmetz T, Dotan I (2025) Safety of sodium-glucose cotransporter 2 inhibitors in kidney transplant recipients with diabetes mellitus. Diabetes Metab 51(3):101627. https:\/\/doi.org\/10.1016\/j.diabet.2025.101627 (Epub 2025 Feb 15)","journal-title":"Diabetes Metab"},{"issue":"8","key":"2792_CR7","doi-asserted-by":"publisher","first-page":"e14718","DOI":"10.1111\/ctr.14718","volume":"36","author":"A Lemke","year":"2022","unstructured":"Lemke A, Brokmeier HM, Leung SB, Mara KC, Mour GK, Wadei HM, Hill JM, Stegall M, Kudva YC, Shah P, Kukla A (2022) Sodium-glucose cotransporter 2 inhibitors for treatment of diabetes mellitus after kidney transplantation. Clin Transpl 36(8):e14718. https:\/\/doi.org\/10.1111\/ctr.14718 (Epub 2022 May 30)","journal-title":"Clin Transpl"},{"issue":"4","key":"2792_CR8","doi-asserted-by":"publisher","first-page":"664","DOI":"10.2215\/CJN.0000000951","volume":"21","author":"VS Sridhar","year":"2026","unstructured":"Sridhar VS, Kugathasan L, Lytvyn Y, Liu H, Deng Y, Lovblom LE, Nardone M, Yuen DA, Chen Y, Hua J, Aronson Y, Mohsen M, Kim SJ, Udell JA, Perkins BA, Stevens J, Touw DJ, Heerspink HJL, Cherney DZI, Singh SKS (2026) Efficacy, mechanisms, and safety of sodium-glucose cotransporter-2 inhibitors in kidney transplant recipients: a randomized, double-blind, placebo-controlled trial. Clin J Am Soc Nephrol 21(4):664\u2013679. https:\/\/doi.org\/10.2215\/CJN.0000000951 (Epub 2025 Dec 12)","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"2792_CR9","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3390\/jcm15010181","volume":"15","author":"RET Navarrete","year":"2025","unstructured":"Navarrete RET, Freitas J, Fonseca I, Cunha A, Sa JR, Martins S (2025) GLP-1 receptor agonists and SGLT2 inhibitors in stable kidney transplantation: clinical outcomes from a cohort of patients with post-transplant diabetes mellitus. J Clin Med 15(1):181. https:\/\/doi.org\/10.3390\/jcm15010181","journal-title":"J Clin Med"},{"issue":"1","key":"2792_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/MNH.0000000000000948","volume":"33","author":"G Mahalwar","year":"2024","unstructured":"Mahalwar G, Mathew RO, Rangaswami J (2024) Sodium-glucose cotransporter 2 inhibitors and cardiorenal outcomes in kidney transplantation. Curr Opin Nephrol Hypertens 33(1):53\u201360. https:\/\/doi.org\/10.1097\/MNH.0000000000000948 (Epub 2023 Nov 6)","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"9","key":"2792_CR11","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1016\/j.ajt.2025.03.019","volume":"25","author":"FS Yen","year":"2025","unstructured":"Yen FS, Hsu CC, Yeh YK, Cheng WY, Liao PL, Hwu CM, Wei JC (2025) The impact of sodium-glucose cotransporter-2 inhibitors on dialysis risk and mortality in kidney transplant patients with diabetes. Am J Transpl 25(9):1954\u20131964 (Epub 2025 Mar 21)","journal-title":"Am J Transpl"},{"issue":"8","key":"2792_CR12","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1016\/j.ekir.2024.05.022","volume":"9","author":"JH Lim","year":"2024","unstructured":"Lim JH, Kwon S, Seo YJ, Kim YH, Kwon H, Kim YS, Lee H, Kim YL, Kim CD, Park SH, Hwang D, Yun WS, Kim HK, Huh S, Lee JS, Yoo KD, Jeong JC, Lee J, Lee JP, Cho JH (2024) Cardioprotective effect of SGLT2 inhibitor in diabetic kidney transplant recipients: a multicenter propensity score matched study. Kidney Int Rep 9(8):2474\u20132483. https:\/\/doi.org\/10.1016\/j.ekir.2024.05.022","journal-title":"Kidney Int Rep"},{"key":"2792_CR13","doi-asserted-by":"publisher","first-page":"329","DOI":"10.12688\/f1000research.162502.1","volume":"14","author":"K Boonpiraks","year":"2025","unstructured":"Boonpiraks K, Krisanapan P, Anumas S, Thongprayoon C, Cheungpasitporn W, Pattharanitima P (2025) The efficacy and safety of SGLT2 inhibitors in diabetes kidney transplant recipients: a systematic review and meta-analysis. F1000Res 14:329. https:\/\/doi.org\/10.12688\/f1000research.162502.1","journal-title":"F1000Res"},{"issue":"1","key":"2792_CR14","doi-asserted-by":"publisher","first-page":"e217","DOI":"10.1097\/TP.0000000000005496","volume":"110","author":"SA Lee","year":"2026","unstructured":"Lee SA, Verhoeff R, Hullekes F, Hansrivijit P, de Bruin RWF, Porte RJ, Riella LV (2026) SGLT2 inhibitors and GLP-1 receptor agonists in kidney transplantation: a systematic review and meta-analysis. Transplantation 110(1):e217\u2013e228. https:\/\/doi.org\/10.1097\/TP.0000000000005496","journal-title":"Transplantation"},{"issue":"11","key":"2792_CR15","doi-asserted-by":"publisher","first-page":"e70365","DOI":"10.1111\/ctr.70365","volume":"39","author":"E Anderson","year":"2025","unstructured":"Anderson E, Shabanowitz S, Jessup K, Allen RB, Chandran M, Yang A (2025) Impact of sodium-glucose cotransporter-2 inhibitors on proteinuria in kidney transplant recipients. Clin Transpl 39(11):e70365. https:\/\/doi.org\/10.1111\/ctr.70365","journal-title":"Clin Transpl"},{"key":"2792_CR16","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.5646\/ch.2025.31.e26","volume":"31","author":"L Basl\u00e9","year":"2025","unstructured":"Basl\u00e9 L, Maigret L, Dupont V, Li\u00e8vre L, Bouvier N, Duthe F, Perrin P, Jaureguy M, Golbin L, Garrouste C, Rerolle JP, Bertrand D, Rieu P, Gatault P, Deli\u00e8ge PG (2025) Impact of SGLT2 inhibitors on blood pressure among kidney transplant recipients: insights from a French multicentric cohort (GREAT ASTRE). Clin Hypertens 31:e26. https:\/\/doi.org\/10.5646\/ch.2025.31.e26","journal-title":"Clin Hypertens"},{"issue":"7","key":"2792_CR17","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.3390\/ijms26073351","volume":"26","author":"I P\u00e9rez-Flores","year":"2025","unstructured":"P\u00e9rez-Flores I, L\u00f3pez-Pastor AR, G\u00f3mez-Pinedo U, G\u00f3mez-Infantes A, Espino-Pais\u00e1n L, Calvo Romero N, de la Moreno MA, Rodr\u00edguez-Cubillo B, G\u00f3mez-Delgado I, S\u00e1nchez-Fructuoso AI, Urcelay E (2025) Mitochondrial changes induced by SGLT2i in lymphocytes from diabetic kidney transplant recipients: a pilot study. Int J Mol Sci 26(7):3351. https:\/\/doi.org\/10.3390\/ijms26073351","journal-title":"Int J Mol Sci"},{"issue":"7","key":"2792_CR18","doi-asserted-by":"publisher","first-page":"107449","DOI":"10.1016\/j.medcli.2026.107449","volume":"166","author":"P Fraile G\u00f3mez","year":"2026","unstructured":"Fraile G\u00f3mez P, L\u00f3pez Cano M, Villanueva S\u00e1nchez E, Lizarazo Suarez A, S\u00e1nchez-Montero S, Lorenzo G\u00f3mez F (2026) Use of ISGLT2 in kidney transplant recipients without diabetes mellitus. Med Clin (Barc) 166(7):107449. https:\/\/doi.org\/10.1016\/j.medcli.2026.107449 (English, Spanish. Epub ahead of print)","journal-title":"Med Clin (Barc)"},{"key":"2792_CR19","doi-asserted-by":"publisher","unstructured":"Guillot D, Dejoie T, Kerleau C, Walencik A, Dantal J, Maillard C, Legouis D, Figueres L (2026 May) Dapagliflozin corrects hypomagnesemia in kidney-transplant patients. J Nephrol 23:aajag046. https:\/\/doi.org\/10.1093\/joneph\/aajag046 (Epub ahead of print)","DOI":"10.1093\/joneph\/aajag046"},{"issue":"12","key":"2792_CR20","doi-asserted-by":"publisher","first-page":"759","DOI":"10.4149\/BLL_2024_116","volume":"125","author":"P Kleinova","year":"2024","unstructured":"Kleinova P, Granak K, Vnucak M, Beliancinova M, Blichova T, Dedinska I (2024) The sodium-glucose cotransporter-2 inhibitors in patients with chronic kidney disease with or without kidney transplantation - a single centre study. Bratisl Lek Listy 125(12):759\u2013765. https:\/\/doi.org\/10.4149\/BLL_2024_116","journal-title":"Bratisl Lek Listy"},{"key":"2792_CR21","doi-asserted-by":"publisher","first-page":"1332397","DOI":"10.3389\/fneph.2024.1332397","volume":"4","author":"E Polychronopoulou","year":"2024","unstructured":"Polychronopoulou E, Bourdon F, Teta D (2024) SGLT2 inhibitors in diabetic and non-diabetic kidney transplant recipients: current knowledge and expectations. Front Nephrol 4:1332397. https:\/\/doi.org\/10.3389\/fneph.2024.1332397","journal-title":"Front Nephrol"},{"issue":"3","key":"2792_CR22","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.ekir.2024.11.033","volume":"10","author":"L Maigret","year":"2024","unstructured":"Maigret L, Basle L, Chatelet V, Ecotiere L, Perrin P, Golbin L, Bertrand D, Anglicheau D, Poulain C, Garrouste C, Danthu C, Boud\u2019hors C, Le Meur Y, Dekeyser M, Duthe F, Sautenet B, Deli\u00e8ge PG, Gatault P (2024) Sodium-Glucose Cotransporter-2 Inhibitor in Diabetic and Nondiabetic Renal Transplant Recipients. Kidney Int Rep 10(3):816\u2013827. https:\/\/doi.org\/10.1016\/j.ekir.2024.11.033","journal-title":"Kidney Int Rep"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-026-02792-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00592-026-02792-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-026-02792-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T03:02:48Z","timestamp":1788231768000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00592-026-02792-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":22,"alternative-id":["2792"],"URL":"https:\/\/doi.org\/10.1007\/s00592-026-02792-4","relation":{},"ISSN":["1432-5233"],"issn-type":[{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]},"assertion":[{"value":"8 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Gazi University Clinical Research Ethics Committee for Non-Interventional Clinical Research, Ankara, T\u00fcrkiye (decision no: 179; meeting date: 13 December 2021). The approved study title was \u201cRetrospective Evaluation of the Efficacy and Safety of SGLT-2 Inhibitor Use in Renal Transplant Recipients with Diabetes Mellitus.\u201d The study was conducted in accordance with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all participants.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No organs or tissues used in this study were obtained from prisoners. All kidney transplant procedures and follow-up care were performed through the Gazi University Faculty of Medicine Kidney Transplantation Program, Ankara, T\u00fcrkiye, in accordance with applicable national regulations and institutional procedures.","order":4,"name":"Ethics","label":"Human transplantation","group":{"name":"EthicsHeading","label":"Declarations"}}]}}